While cancer genetic research has focused very extensively on the exome over recent decades, given that mutations within coding sequence may clearly impact significantly on the protein products of these genes to contribute to oncogenesis, it has emerged more recently that dysregulation at an epigenetic level, resulting for example from mutation in subunits of the BAF complex, may in fact contribute considerably to cancer development as well as progression [35,36,37,38,39,40]. Here, BANF1 is linked to cancer.